IMNM
USDImmunome Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$16.360
High
$16.800
Low
$15.060
Volume
0.74M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.31M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the "company") (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Nov. 3, 2025, the Compensation Committee of
Immunome to Present at 2nd Annual Guggenheim Healthcare Innovation Conference
Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced that Immunome management will present at the 2nd Annual Guggenheim
Immunome Presents Preclinical Data Showing Proprietary TOP1i ADC Payload HC74 Overcomes Multiple Mechanisms of ADC Resistance
Immunome, Inc. (NASDAQ:IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, recently presented preclinical data showing its proprietary antibody-drug conjugate
Related Stocks
TCRT
Alaunos Therapeutics Inc.
IMMX
Immix Biopharma Inc.
TTI
Tetra Technologies Inc.
OPP
RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
TPZ
Tortoise Power and Energy Infrastructure Fund Inc
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.